|
|
Blood, 1 May 2006, Vol. 107, No. 9, pp. 3537-3545.
Prepublished online as a Blood First Edition Paper on January 31, 2006; DOI 10.1182/blood-2005-02-0618.
Previous Article | Next Article 
Submitted February 14, 2005
Accepted December 19, 2005
Mechanism of platelet adhesion to von Willebrand factor and microparticle formation under high shear stress
Armin J Reininger*, Harry F Heijnen, Hannah Schumann, Hanno M Specht, Wolfgang Schramm, and Zaverio M Ruggeri
Department of Transfusion Medicine and Hemostaseology, Clinic for Anesthesiology, University Clinic Munich, Ludwig-Maximilians-University, Munich, Germany
Department of Hematology, Division of Thrombosis and Hemostasis, and Department of Cell Biology, University Medical Center, Utrecht, The Netherlands
Roon Center for Arteriosclerosis and Thrombosis, Division of Experimental Hemostasis and Thrombosis, Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA, USA
* Corresponding author; email: armin.reininger{at}med.uni-muenchen.de.
We describe here the mechanism of platelet adhesion to immobilized von Willebrand factor (VWF) and subsequent formation of platelet-derived microparticles mediated by glycoprotein (GP) Ib under high shear stress. As visualized in whole blood perfused in a flow chamber, platelet attachment to VWF involved one or few membrane areas of 0.05-0.1 µm2 that formed discrete adhesion points (DAPs) capable of resisting force in excess of 160 pN. Under the influence of hydrodynamic drag, membrane tethers developed between the moving platelet body and DAPs firmly adherent to immobilized VWF. Continued stretching eventually caused the separation of many such tethers, leaving on the surface tube-shaped or spherical microparticles with a diameter as low as 50-100 nanometers. Adhesion receptors (GP Ib , IIb 3) and phosphatidylserine were expressed on the surface of these microparticles, which were procoagulant. Shearing platelet-rich plasma at the rate of 10,000 s-1 in a cone-and-plate viscosimeter increased microparticle counts up to 55-fold above baseline. Blocking the GP Ib -VWF interaction abolished microparticle generation in both experimental conditions. Thus, a biomechanical process mediated by GP Ib -VWF bonds in rapidly flowing blood may not only initiate platelet arrest onto reactive vascular surfaces, but also generate procoagulant microparticles that further enhance thrombus formation.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
"Pulling strings": shear, platelets, and microparticles
- Shaun P. Jackson, Pierre Mangin, and Yuping Yuan
Blood 2006 107: 3418-3419.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
H. Cheng, R. Yan, S. Li, Y. Yuan, J. Liu, C. Ruan, and K. Dai
Shear-induced interaction of platelets with von Willebrand factor results in glycoprotein Ib{alpha} shedding
Am J Physiol Heart Circ Physiol,
December 1, 2009;
297(6):
H2128 - H2135.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Rodeghiero, G. Castaman, and A. Tosetto
How I treat von Willebrand disease
Blood,
August 6, 2009;
114(6):
1158 - 1165.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Kleinschnitz, S. F. De Meyer, T. Schwarz, M. Austinat, K. Vanhoorelbeke, B. Nieswandt, H. Deckmyn, and G. Stoll
Deficiency of von Willebrand factor protects mice from ischemic stroke
Blood,
April 9, 2009;
113(15):
3600 - 3603.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Ayers, B. Ferry, S. Craig, D. Nicoll, J. R. Stradling, and M. Kohler
Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea
Eur. Respir. J.,
March 1, 2009;
33(3):
574 - 580.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. O. Spiel, J. C. Gilbert, and B. Jilma
Von Willebrand Factor in Cardiovascular Disease: Focus on Acute Coronary Syndromes
Circulation,
March 18, 2008;
117(11):
1449 - 1459.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Gilbert, T. DeFeo-Fraulini, R. M. Hutabarat, C. J. Horvath, P. G. Merlino, H. N. Marsh, J. M. Healy, S. BouFakhreddine, T. V. Holohan, and R. G. Schaub
First-in-Human Evaluation of Anti von Willebrand Factor Therapeutic Aptamer ARC1779 in Healthy Volunteers
Circulation,
December 4, 2007;
116(23):
2678 - 2686.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P. Jackson
The growing complexity of platelet aggregation
Blood,
June 15, 2007;
109(12):
5087 - 5095.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Schwertz, N. D. Tolley, J. M. Foulks, M. M. Denis, B. W. Risenmay, M. Buerke, R. E. Tilley, M. T. Rondina, E. M. Harris, L. W. Kraiss, et al.
Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenecity of human platelets
J. Exp. Med.,
October 30, 2006;
203(11):
2433 - 2440.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. M. Ruggeri, J. N. Orje, R. Habermann, A. B. Federici, and A. J. Reininger
Activation-independent platelet adhesion and aggregation under elevated shear stress
Blood,
September 15, 2006;
108(6):
1903 - 1910.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Boulanger, N. Amabile, and A. Tedgui
Circulating Microparticles: A Potential Prognostic Marker for Atherosclerotic Vascular Disease
Hypertension,
August 1, 2006;
48(2):
180 - 186.
[Full Text]
[PDF]
|
 |
|
|
|